Joint

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Joint (JYNT) posts record sales in Q4 2022, eyes strategic growth

Joint (JYNT) delivered strong financial performance in Q4 2022, driven by record clinic openings and successful marketing initiatives.
While facing challenges such as labor costs and franchise sales impact, the company is focused on margin expansion and strategic growth opportunities.
With a positive outlook for 2023 revenue and adjusted EBITDA, Joint (JYNT) aims to navigate challenges and capitalize on opportunities for sustained success.
The company's commitment to patient care, operational efficiency, and financial planning positions it well for future growth and profitability.

Joint Corp. posts impressive Q1 results amidst digital marketing evolution

Joint Corp. delivered robust Q1 2023 results with strong sales growth and operational performance across its clinic network.
While facing competitive pressures and marketing challenges, the company's focus on efficiency and patient acquisition strategies bodes well for future growth.
Adapting to digital marketing trends and leveraging upcoming events can position Joint Corp. for sustained success and investor confidence.

Joint (JYNT) reports strong Q2 growth, focuses on profitability

Joint (JYNT) reported solid growth in system-wide sales and clinic openings, with profitability around 20% despite challenges.
The company is actively addressing operational issues, optimizing its clinic portfolio, and focusing on cost savings initiatives.
Strategic planning for profitability and efficiency in 2024 and beyond is underway, with a commitment to long-term success.
Partnerships, marketing expansions, and ongoing reviews present opportunities for growth and market expansion for Joint (JYNT).

The Joint Corp. reports stable Q3 earnings, shifts focus to franchises

The Joint Corp. delivered solid financial performance in Q3 2023, with a focus on refranchising and enhancing franchise clinic operations.
Efforts to boost new patient starts and optimize marketing strategies are driving positive trends in conversion rates and sales.
While facing challenges in new patient counts and franchise sales, the company is strategically positioning itself for long-term success.

The Joint Corp. reports robust 2023 performance and strategic growth plans

The Joint Corp. delivered strong financial performance in 2023, with notable growth in sales, revenue, and patient metrics.
Strategic initiatives like refranchising and local store marketing offer growth opportunities and cost-saving potential for the company.
Challenges include managing the transition of company-owned clinics and balancing marketing expenses with revenue growth objectives.
Overall, The Joint Corp. is well-positioned to capitalize on its operational strengths and market opportunities for sustained growth and success.

The Joint Corp. triples franchise sales and boosts financial performance

The Joint Corp. delivered strong financial performance in Q1 2024, marked by revenue growth, improved bottom line, and significant franchise sales growth, supported by robust marketing strategies.
While facing potential risks and challenges, the company's focus on EBITDA, franchise expansion, and talent development positions it well for future growth and operational excellence.
Opportunities in marketing innovation, talent development, and operational efficiency present avenues for sustained growth and value creation, aligning with the company's commitment to performance and brand enhancement.
Overall, The Joint Corp.'s Q1 2024 earnings call highlighted a strategic roadmap for success, emphasizing growth, excellence in patient care, and financial transparency to drive shareholder value.

The Joint Corp. reports revenue growth and strategic focus on clinics

The Joint Corp. reported positive revenue growth in Q2 2024, driven by same-store comps and operational improvements.
While facing financial challenges and impact on franchise sales, the company's strategic focus on clinic optimization and patient loyalty is a key strength.
Future opportunities lie in expanding the clinic network, enhancing profitability, and driving patient loyalty through innovative strategies.
Overall, The Joint Corp. is positioned for growth with a strong foundation of clinics and a focus on improving financial performance and patient experiences.

Joint Corp (JYNT) reports robust Q3 performance amidst operational enhancements

Joint Corp's Q3 2024 earnings call highlighted strong performance metrics, a strategic focus on patient care and operational efficiency, and challenges related to consumer headwinds and refranchising efforts. The company is well-positioned to capitalize on growth opportunities by leveraging its infrastructure and exploring new service offerings.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

SCOTTSDALE, Ariz., Feb. 18, 2021 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its fourth quarter 2020 financial results on Thursday, March 4, 2021, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. ET that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, March 4th to Discuss Fourth Quarter 2020 Results

The chiropractic clinic franchise has revolutionized how people treat back pain.

Buy Alert: The Joint Corp. Stock Is Headed Higher

SCOTTSDALE, Ariz., Jan. 15, 2021 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, the University of South Florida (USF) and Vinik Sports Group (VSG) recently signed an agreement naming The Joint as...

The Joint Chiropractic is the Official Chiropractor of South Florida Athletics

Up almost 170% since late March, this company is riding the wellness craze.

1 Red-Hot Healthcare Stock That Could Double Your Money

- Increases Margin Contribution to the Company – - Increases Margin Contribution to the Company –

The Joint Corp. Acquires Two Regional Developer Territories

JYNT has soared this year on strong growth. But it is just getting started as new offices open and margins look to improve.

The Joint Corp.: Huge Growth Is Still To Come

Molina Healthcare

UnitedHealth Group

We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.

3 Health Insurers That Crushed S&P YTD, Set to Rise Further

SCOTTSDALE, Ariz., Nov. 30, 2020 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management is scheduled to participate in the Roth Virtual Deer Valley Conference, December 10 – 11, 2020.

The Joint Corp. to Participate in the Roth Virtual Deer Valley Consumer Conference

SCOTTSDALE, Ariz., Nov. 10, 2020 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, honors Veterans today and every day with its year-round Military Appreciation Program. The exclusive benefit offers...

The Joint Chiropractic Honors Veterans Day

The Joint Corp. (JYNT) CEO Peter Holt on Q3 2020 Results - Earnings Call Transcript

SCOTTSDALE, Ariz., Oct. 22, 2020 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its third quarter 2020 financial results on Thursday, November 5, 2020, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. ET that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, November 5th to Discuss Third Quarter 2020 Results

The Joint Corp: A Niche Play In The Wellness Trend, With A Rewarding Investment Case

SCOTTSDALE, Ariz., Oct. 1, 2020 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, is encouraging Americans to consider their spinal wellbeing this October, Spinal Health Month. Since the onset of...

The Joint Chiropractic Observes Spinal Health Month in October

As of late, it has definitely been a great time to be an investor in The Joint Corp.

Joint Corp's Shares March Higher, Can It Continue?

LaZBoy

Medpace Holdings

Novanta

Top Ranked Momentum Stocks to Buy for August 28th

Humana

Select Medical Holdings

Solid Near-Term HMO Industry Prospects on Multiple Tailwinds

SCOTTSDALE, Ariz., Aug.  18, 2020  (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management plans to present and conduct one-on-one meetings at these conferences in September 2020.

The Joint Corp. to Participate in Upcoming Virtual Conferences

SCOTTSDALE, Ariz., Aug. 13, 2020 /PRNewswire/ -- As part of its commitment to get Americans moving, The Joint Corp.

The Joint Chiropractic Gives Over $1.7 Million Worth of Free Chiropractic Care to New Patients in June

The Joint's (JYNT) CEO Peter Holt on Q2 2020 Results - Earnings Call Transcript

The Joint Corp.: Bare Bones Chiropractor Targeting 2x Growth By 2023

The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Earnings Preview: The Joint Corp. (JYNT) Q2 Earnings Expected to Decline

SCOTTSDALE, Ariz., July  23, 2020  (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its second quarter 2020 financial results on Thursday, August 6, 2020, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. ET that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, August 6th to Discuss Second Quarter 2020 Results

Patterson Companies

ResMed

West Pharmaceutical Services

Here are some MedTech stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.

4 Best MedTech Stocks to Combat Coronavirus Crisis on Strong ROE

Booking Hlds

Universal Display

To increase the likelihood to come across high-quality investments, one strategy is to look for reasonably-priced stocks of companies with good financials that are predicted to increase their earnings per share (EPS) significantly.

3 Stocks Trading at Tempting Valuations

Increases Corporate Clinic Count to 63 as of July 1, 2020 Increases Corporate Clinic Count to 63 as of July 1, 2020

News for Joint Stock (JYNT)